[Open-bio-l] BioSQL schema: some questions
Ewan Birney
birney@ebi.ac.uk
Sun, 28 Apr 2002 22:50:44 +0100 (BST)
On Sat, 27 Apr 2002, Hilmar Lapp wrote:
> >
> > molecule = where it came from (eg mRNA)
> >
> > alphabet = how it is encoded (DNA/RNA etc)
> >
>
> Shouldn't then molecule be an attribute of Bioentry? Likewise, shouldn't alphabet be added to Bioentry?
One would hope these are both biosequence properties, in partuclar the
alphabet
>
> >
> > > > 17) Aren't Dbxref.dbname and Biodatabase.name redundant?
> > Shouldn't there
> > > > be a FK?
> > >
> > > pass
> > >
> >
> > Not dbref.dbnames will be biodatabase.name, in particular in
> > things like
> > swissport which going link-tastic v. quickly.
> >
>
> Sorry. I'm not sure I understand what you mean.
>
Swissprot has alot of DR lines with alot of databases, most of which one
does not want to instatiate a database entry for (although one
could...) each which has it own pecularities about id tracking.
> -hilmar
> --
> -------------------------------------------------------------
> Hilmar Lapp email: lapp@gnf.org
> GNF, San Diego, Ca. 92121 phone: +1-858-812-1757
> -------------------------------------------------------------
>
>
-----------------------------------------------------------------
Ewan Birney. Mobile: +44 (0)7970 151230, Work: +44 1223 494420
<birney@ebi.ac.uk>.
-----------------------------------------------------------------